Enteric fever, primarily caused by Salmonella Typhi and Salmonella Paratyphi, remains a significant health concern worldwide, particularly in developing countries. Despite advances in healthcare, effective management of enteric fever in clinical practice remains challenging. This article aims to explore the most effective strategies for managing this condition.
Rapid and accurate diagnosis is the cornerstone of effective management. Blood culture remains the gold standard for diagnosis, but its sensitivity can be limited. Newer diagnostic techniques, such as PCR and serological tests, offer promising alternatives.
Antibiotic therapy is the mainstay of treatment for enteric fever. However, the increasing prevalence of multidrug-resistant strains requires careful antibiotic selection. Fluoroquinolones, third-generation cephalosporins, and azithromycin are currently the drugs of choice.
Vaccination is a crucial preventive measure. Two vaccines - the oral live attenuated Ty21a vaccine and the injectable Vi polysaccharide vaccine - are currently available. However, their efficacy varies, and they are not suitable for all populations. Continued research into more effective vaccines is needed.
Public health measures, such as improved sanitation and safe drinking water, play a significant role in preventing enteric fever. These measures are particularly important in endemic areas where antibiotic resistance is high.
Effective management of enteric fever requires a multifaceted approach, including accurate diagnosis, appropriate antibiotic therapy, vaccination, and public health measures. Clinicians must stay abreast of the latest developments in diagnosis and treatment, while public health initiatives must focus on prevention. As antibiotic resistance continues to rise, the need for new treatment strategies and vaccines becomes increasingly urgent.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation